116 related articles for article (PubMed ID: 10497905)
1. Possible inhibitory mechanism of FK506 (tacrolimus hydrate) ointment for atopic dermatitis based on animal models.
Sengoku T; Morita K; Sakuma S; Motoyama Y; Goto T
Eur J Pharmacol; 1999 Aug; 379(2-3):183-9. PubMed ID: 10497905
[TBL] [Abstract][Full Text] [Related]
2. Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice.
Hiroi J; Sengoku T; Morita K; Kishi S; Sato S; Ogawa T; Tsudzuki M; Matsuda H; Wada A; Esaki K
Jpn J Pharmacol; 1998 Feb; 76(2):175-83. PubMed ID: 9541280
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological profile and clinical effect of tacrolimus ointment (Protopic ointment) for atopic dermatitis].
Hiroi J
Nihon Yakurigaku Zasshi; 2001 May; 117(5):351-7. PubMed ID: 11411345
[TBL] [Abstract][Full Text] [Related]
4. [Effects of tacrolimus ointment on type I (immediate and late) and IV (delayed) cutaneous allergic reactions in mice].
Sengoku T; Morita K; Sato S; Sakuma S; Ogawa T; Hiroi J; Fujii T; Goto T
Nihon Yakurigaku Zasshi; 1998 Sep; 112(3):221-32. PubMed ID: 9793077
[TBL] [Abstract][Full Text] [Related]
5. Topical application of FK506 (tacrolimus) ointment inhibits mite antigen-induced dermatitis by local action in NC/Nga mice.
Sasakawa T; Higashi Y; Sakuma S; Hirayama Y; Sasakawa Y; Ohkubo Y; Mutoh S
Int Arch Allergy Immunol; 2004 Jan; 133(1):55-63. PubMed ID: 14726632
[TBL] [Abstract][Full Text] [Related]
6. Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects.
Wang Y; Cao S; Yu K; Yang F; Yu X; Zhai Y; Wu C; Xu Y
Int J Nanomedicine; 2019; 14():5849-5863. PubMed ID: 31440050
[No Abstract] [Full Text] [Related]
7. Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis.
Yamashita H; Ito T; Kato H; Asai S; Tanaka H; Nagai H; Inagaki N
Eur J Pharmacol; 2010 Oct; 645(1-3):171-6. PubMed ID: 20674565
[TBL] [Abstract][Full Text] [Related]
8. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
Cheer SM; Plosker GL
Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
Rico MJ; Lawrence I
Allergy Asthma Proc; 2002; 23(3):191-7. PubMed ID: 12125507
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids).
Sakuma S; Higashi Y; Sato N; Sasakawa T; Sengoku T; Ohkubo Y; Amaya T; Goto T
Int Immunopharmacol; 2001 Jun; 1(6):1219-26. PubMed ID: 11407316
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment.
Aoyama H; Tabata N; Tanaka M; Uesugi Y; Tagami H
Br J Dermatol; 1995 Sep; 133(3):494-6. PubMed ID: 8547017
[No Abstract] [Full Text] [Related]
13. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.
Yu K; Wang Y; Wan T; Zhai Y; Cao S; Ruan W; Wu C; Xu Y
Int J Nanomedicine; 2018; 13():129-142. PubMed ID: 29317821
[TBL] [Abstract][Full Text] [Related]
14. Atopic dermatitis management with tacrolimus ointment (Protopic).
Kapp A; Allen BR; Reitamo S
J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634
[TBL] [Abstract][Full Text] [Related]
15. Effect of FK506 eye drops on late and delayed-type responses in ocular allergy models.
Sengoku T; Sakuma S; Satoh S; Kishi S; Ogawa T; Ohkubo Y; Mutoh S
Clin Exp Allergy; 2003 Nov; 33(11):1555-60. PubMed ID: 14616868
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus ointment for atopic dermatitis.
Marone G
N Engl J Med; 1998 Dec; 339(24):1788; author reply 1788-9. PubMed ID: 9867559
[No Abstract] [Full Text] [Related]
17. Recall antigen reactions in patients with atopic dermatitis treated with tacrolimus ointment for 1 year.
Mandelin J; Remitz A; Virtanen H; Reitamo S
J Allergy Clin Immunol; 2008 Mar; 121(3):777-9. PubMed ID: 18328896
[No Abstract] [Full Text] [Related]
18. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus: focusing on atopic dermatitis.
Carroll CL; Fleischer AB
Drugs Today (Barc); 2006 Jul; 42(7):431-9. PubMed ID: 16894398
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.
Simpson D; Noble S
Drugs; 2005; 65(6):827-58. PubMed ID: 15819596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
